Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 9:00 PM ET

Date/Time Source News Release
12/04/2024 07:35 AM EST GlobeNewswire Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy
11/19/2024 07:25 AM EST GlobeNewswire Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary
11/12/2024 07:35 AM EST GlobeNewswire Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
11/06/2024 07:35 AM EST GlobeNewswire Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
10/31/2024 07:35 AM EDT GlobeNewswire Appendix 4C - Q1 FY25 Quarterly Cash Flow Report
10/14/2024 07:35 AM EDT GlobeNewswire Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
10/11/2024 07:35 AM EDT GlobeNewswire Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
10/02/2024 07:35 AM EDT GlobeNewswire Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson's Disease and Movement Disorders®
09/30/2024 07:35 AM EDT GlobeNewswire Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
09/23/2024 07:35 AM EDT GlobeNewswire Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson's Disease and Movement Disorders®
Page

Additional News

As of January 5, 2025 • 9:00 PM ET

Date/Time Source News Release
09/30/2024 08:00 AM EDT SeekingAlpha Alterity Therapeutics appoints Abby Macnish Niven as CFO
08/25/2024 08:01 AM EDT SeekingAlpha Earnings week ahead: NVIDIA, CrowdStrike, Salesforce, Lululemon and more
07/18/2024 11:01 AM EDT Zacks Alterity (ATHE) Up on Interim Data From Advance MSA Study
07/17/2024 12:37 PM EDT SeekingAlpha Alterity stock climbs 8% on positive Phase 2 data for ATH434-202
04/15/2024 12:47 PM EDT SeekingAlpha BSGM, ENLV and WISA among mid-day movers
04/15/2024 08:21 AM EDT SeekingAlpha NXPL, MGRM and OCX among pre-market losers
04/11/2024 08:16 AM EDT SeekingAlpha ATUS, ATHE and GRFS among pre-market losers
03/26/2024 11:11 AM EDT SeekingAlpha Alterity Therapeutics receives A$3.9M research & development tax incentive refund
02/23/2024 01:39 PM EST SeekingAlpha Alterity Therapeutics drops on capital raise
02/23/2024 10:00 AM EST SeekingAlpha Vir Biotechnology, Community Health Systems among healthcare movers
Page